Peripheral neuropathy Board decisions

The veteran's claims for service connection for several conditions, including low back disability and diabetes mellitus, type II, were granted. The claim for rheumatic fever was remanded.

The Board remanded all issues for new VA examinations due to inadequate previous exams and missing records.

The veteran is granted a 20% rating for bladder cancer residuals starting from December 5, 2022. Service connection for peripheral neuropathy in all extremities was denied.

The veteran's appeal for increased disability ratings was partially granted. The veteran received a higher rating for coronary artery disease and both sciatic neuropathies, but the appeal for higher ratings for femoral neuropathies was denied.

The veteran was granted a 30% rating for their chronic left foot injury with pes planus and plantar fasciitis from March 17, 2021 to December 6, 2021. All other issues were denied or remanded.

The Board dismissed all appeals due to untimely filing of the notice of disagreement. The Veteran is encouraged to file a supplemental claim.

The Board granted service connection for diabetes mellitus, type II; ischemic heart disease; and peripheral neuropathy in all four extremities.

The appeal was dismissed because the veteran died while it was pending.

The Board remanded all claims for service connection due to insufficient evidence and the need for further medical examinations.

The Board denied the veteran's claim for a rating higher than 20% for left ulnar nerve peripheral neuropathy. The evidence showed moderate, not severe, impairment.

The Board remanded all issues on appeal, including service connection for cervical disability, right shoulder disability, and right upper extremity neuropathy, as well as a higher rating for PTSD and TDIU. The Veteran's motion to advance the claim due to severe financial hardship was granted.

The Veteran's service-connected disabilities require regular aid and attendance, so he is granted special monthly compensation (SMC).

The Board remanded the claims for service connection for left and right lower extremity peripheral neuropathy, and sleep apnea due to new and relevant evidence. The claim for a low back disorder was not remanded.

The veteran's appeal resulted in a mixed decision. Some ratings were granted, such as a 30 percent rating for anemia secondary to diabetes mellitus and increased ratings for diabetic neuropathy. However, other claims, including higher ratings for diabetes mellitus and earlier effective dates for service connection, were denied.

The Board granted service connection for hypertension and denied it for ischemic heart disease. Several other claims were remanded for further development.

The veteran's claims for service connection for various neuropathies and depression were dismissed due to procedural defects. The veteran was granted a 70% disability rating for PTSD from February 16, 2023, to December 27, 2023, but denied a higher rating.

The veteran was granted a 40% disability rating for diabetic peripheral neuropathy in both legs, but this was later reduced to 10%. The veteran was denied a higher rating for eye conditions and adaptive equipment.

The Veteran's claim for an initial evaluation in excess of 10 percent for chronic lumbosacral musculoligamentous strain from July 26, 2007 through November 11, 2010 was denied. A 20 percent evaluation for the same condition from November 12, 2010 through July 24, 2022 was granted. Similar decisions were made for peripheral neuropathy of both lower extremities.

The veteran's peripheral neuropathy in the left upper extremity, left lower extremity, and right lower extremity is service-connected to their non-Hodgkin's lymphoma. The effective date for these conditions is August 29, 2012. The rating decisions are remanded.

The Board remanded the veteran's claims for service connection of left and right lower extremity peripheral neuropathy. The Board needs more evidence to decide if these conditions are related to military service.